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Abstract
Given their medical importance, natural products represent a tremendous source of drug dis-
covery. The aim of this study was to investigateMalva sylvestris L. extract and fractions and
their pharmacological activities followed by chemical identification. The aqueous fraction (AF)
was identified as the bioactive fraction in the in vitro and in vivo assays. The AF controlled the
neutrophil migration to the peritoneal cavity by 66%, inhibited the antiedematogenic activity by
58.8%, and controlled IL-1β cytokine expression by 54%. The in vitro viability tests showed a
concentration-dependent effect, where the MSE and fractions at concentrations under 10 μg/
mL were non-toxic to cells. Transcriptional factors of carbonic anhydrase II (CAII), cathepsin K
(Ctsk) and tartrate-resistant acid phosphatase (TRAP) were analyzed by qPCR in RAW264.7
cell lines. The gene expression analysis showed that the AF was the only treatment that could
downregulate all the study genes:CAII,Ctsk and TRAP (p<0.05). TRAP staining was used to
evaluate osteoclast formation. AF treatments reduced the number of osteoclastogenesis 2.6-
fold compared to the vehicle control group. Matrix metalloproteinase 9 (MMP-9) activity
decreased 75%with the AF treatment. Moreover, the bioactive fraction had the ability to regu-
late the oxidation pathway in the ABTS (2,2-Azino-bis (3-ethylbenzthiazoline-6-sulfonic acid)
assay with an activity equivalent to 1.30 μmol Trolox/g and DPPH (2,2-diphenyl-1-picrylhydra-
zyl) radicals 1.01 g/L. Positive ion ESI-mass spectrometry for molecular ions at m/z 611 and
633 confirmed rutin as the major compound in the AF. The AF ofM. sylvestris presented anti-
inflammatory, controlled osteoclastogenic mechanisms and antioxidant abilities in different in
vitro and in vivomethods. In addition, we suggest that given its multi-target activity the bioac-
tive fraction may be a good candidate in the therapy of chronic inflammatory diseases.
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Introduction
Inflammation, a biological process that involves vascular and cellular events coordinated by
mediators like prostaglandin, leukotrienes, cytokines and thromboxanes that include an essen-
tial and protective mechanism of the organism in response to injury, infection and trauma
[1,2]. However, prolonged inflammation may lead to chronic diseases including rheumatoid
arthritis and periodontitis, which are associated with tissue injury and bone resorption [2].
During the pathogenesis, pro-inflammatory mediators and reactive oxygen species (ROS) can
promote osteoblast apoptosis and bone resorption through the activation of NF-κB signaling
[3]. The classic pathway for NF-κB stimulation includes an upregulation of RANKL, an osteo-
clastogenic cytokine that induces bone resorption by promoting osteoclast differentiation and
activation [4].
Three peptides and super families RANKL, RANK and OPG regulate the activation and dif-
ferentiation of osteoclasts [5]. RANKL plays an essential role in the differentiation, recruit-
ment, activation, and survival of osteoclasts by binding to its receptor (RANK) on osteoclasts
or progenitor cells [6]. Studies showed that sRANKL and macrophage colony-stimulating fac-
tors (CSF-1/MCSF) factors have the ability to stimulate osteoclast differentiation from periph-
eral blood cell precursors [7]. A number of the RANK-induced signaling pathways in
osteoclasts ultimately induce the expression of enzymes involved in regulating the dissolution
of mineral and collagen, including carbonic anhydrase (CAII), cathepsin K (Ctsk) and tartrate-
resistant acid phosphatase (TRAP) [8,9]. The main role of RANKL is the signaling and the reg-
ulation of homeostasis leading to the system to health or disease state. [7].
In addition, matrix metalloproteinases (MMP) are a family of proteolytic enzymes involved
in extracellular matrix degradation that comprise bone and matrix [6]. Of this group, MMP-9
is an important proteinase that osteoclasts express at high levels. Studies show a correlation
between MMP-9 enzyme activity and the tissue/bone destruction levels in chronic immune-
mediated inflammatory diseases [9,10].
Traditionally, anti-inflammatory therapy has focused on the modulation of pro-inflamma-
tory mediators and/or adhesion molecule expression [11,12]. However, in the past few years it
has been recognized that the inflammation resolution may be based on multi-target drugs [13].
Multiple signaling pathways are a way to improve the pro-inflammatory, immunomodulatory
and pro-resolving cascades, which define the aspects of the inflammation [14].
In this context, natural products have played an important role in the development of new
sources to treat inflammatory diseases [15]. Historically, the screening of sources for natural
products led to the discovery of clinical drugs currently used in the pharmacological therapy
[16]. Nonetheless, since natural products do not have a standard composition and they may
provide compounds with a unique structural activity there is interest in identifying the poten-
tial biological therapeutic in new plant extracts [17].
Malva sylvestris L. ethnopharmacological literature has been in wide use since ancient times
for its emollient, wound healing, antioxidant, antimicrobial and anti-inflammatory properties
[16]. Additionally, it has a long history of use as a food or condiment that can be prepared as sim-
ple additive in soups or salads [17]. Population studies show the incidence of consumption as a
nutraceutical food is particularly due to the presence of fatty acids, which may help prevent sev-
eral diseases and free radical scavenging activity, and protect against chronic diseases [18]. Rec-
ommendations that the plant’s biological activity be used to treat and prevent inflammation is
found in the literature due to the controlling eicosanoid products, including the pro-inflamma-
tory mediator prostaglandin and a variety of cytokine targets like IL-1β IL-6, IL-8 and granulo-
cyte-macrophage colony-stimulating factor GM-CSF. Phytochemical identification shows that
malvidin 3-glucoside, scopoletin and quercetin may be connected to the biological activity [19].
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Due to its widespread and medicinal importance, the aim of this study was to investigate the
extract and fractions ofM. sylvestris in a bioguided phytochemical study for anti-inflammatory,
anti-osteoclastogenic mechanisms and antioxidant effects.
Material and Methods
Ethics statement
Mice were inspected at least once a day and checked for feeding, bedding and all environmental
aspects. Moreover, in the protocol three strategies were included to manage pain and distress:
non-pharmacological approach, pharmacological interventions or euthanasia. The strategy
chosen varied according to the special requirements of each experiment conducted (procedure
performed, type of analgesia, degree, etc.) and followed a veterinarian’s instructions. None of
the animals died prior to the experimental endpoint, but we considered a humane endpoint to
minimize pain and distress. The euthanasia agent was carbon dioxide and a confirmatory cervi-
cal dislocation [20].
Preparation of the extract and fractions
M. sylvestris (Malvaceae) leaves were purchased from a local farmer in the municipality of
“Princesa Isabel”, Paraiba (07°44'12” S and 37°59'36" W). This plant is not an endangered or
protected species and was registered in the herbarium of the University of Sao Paulo (USP),
receiving an identification number (ESA voucher # 121403, Det.: Lopes, S.). The leaves were
dried in a forced circulation oven (Marconi, Piracicaba, Brazil) for 24 h, at a 40°C, and then
crushed in a grinder (30 mesh) to obtain an adequate granulometry. The extraction was con-
ducted with absolute ethanol under climate control (25°C) and subjected to exhaustive extrac-
tion (7 days) in a rotary shaker (Labnet, 211DS) protected against light [19]. In the sequence,
samples were filtered in a qualitative filter (80 g/m2), concentrated by evaporation (Buchi Rota-
vapor; Switzerland) and lyophilized (Christ, Osterode, Germany) for 72 h. The ethanol extract
ofM. sylvestris (MSE) was stored at -20°C. The MSE was re-suspended (1 g/L, in ethanol 70%)
and the mobile solvent system selected according to the sequence: hexane, chloroform and
ethyl acetate. At the end of three partitions, the hexane (HF), chloroform (CLF) and ethyl ace-
tate fractions (EAF) were obtained and the residue was called the aqueous fraction (AF). Sev-
eral extractions were conducted and monitored with thin-layer chromatography (TLC) with
silica gel 60 (Merck1, F-254) used for the stationary phase. The plates were then conditioned
on a glass-lid and flat-bottom chamber pre-saturated with an analytical grade mobile phase of
hexane, acetic acid: ethanol (75: 25: 5). Anisaldehyde reagent (4-methoxybenzaldehyde, acetic
acid, sulfuric acid, (1.0: 48.5: 0.5) was used for the developing process followed by heating in an
oven at 100°C for two minutes [21].
Pharmacological analysis
Anti-inflammatory analysis. Animals:Male Balb/c albino mice (20–25g), SPF (Specific—
pathogen—free), were purchased from CEMIB/UNICAMP (Multidisciplinary Center for Bio-
logical Research, SP, Brazil). The mice were kept in a temperature-controlled room (22 ± 2°C)
for a 12 h light/12 h dark cycle, humidity 40–60%, with food (standard pellet diet) and water
provided ad libitum. The experiments were conducted in accordance with the Guide for the
Care and Use of Laboratory Animals and had received prior approval from the local Animal
Ethics Committee (Comissão de Ética no Uso de Animais (CEUA), Ethics Committee on Ani-
mal Use/UNICAMP, process number 2790–1).
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Neutrophil migration in the peritoneal cavity: To determine the anti-inflammatory activity
of MSE and fractions, the neutrophil migration test was assessed. The animals were randomly
assigned into groups. MSE and the HF, CLF, EAF and AF groups were administered by oral
gavage at concentrations of 3, 10 and 30 mg/kg. The vehicle control group received (saline/etha-
nol 1%) and the positive control dexamethasone (Decadron1) at 1 mg/kg subcutaneously.
Regarding the saline group, all the groups were challenge by intraperitoneal injection of carra-
geenan at 500 μg/mL in naive mice. The mice were euthanized 4 h after the challenge with carra-
geenan. The abdomens were gently massaged and the peritoneal cavity cells were harvested by
washing the cavity with 3 mL of phosphate-buffered saline (PBS) containing EDTA (1 mM). A
blood-free cell suspension was carefully aspirated with a syringe. The volumes recovered were
similar in all experimental groups and equal to approximately 95% of the injected volume. Ali-
quots of peritoneal washing were stored in a freezer at –80°C for subsequent cytokine dosage.
The total counts were performed in a Neubauer chamber. The differential cell count included
100 cells in total presented in smears conducted using a cytocentrifuge (Cytospin 3; Shandon
Lipshaw) and followed by panoptic staining. Cells were counted using an optical microscope
(Carl Zeiss, 40x) and the results were presented as the number of neutrophils per milliliter [22].
Carrageenan-induced paw edema: A paw edema was induced by subplantar injection of
0.05 mL of lambda carrageenan (1% w/v in 0.9% of saline) into the left hind paw of the mice. An
equal volume of vehicle was injected into the contralateral paw. The volume of both hind paws
up to the ankle joint was measured with a plethysmometer (UGO Basile, Model 7140) immedi-
ately before the 0, 1, 2, 3, 4 and 5 h post-carrageenan. The difference in the volumes between the
hind paws was a measure of the edema (mL). The MSE and the bioactive fraction previously
selected in the neutrophil migration model were administered by oral treatment (30 mg/kg).
The reference drug indomethacin (10 mg/kg) was given intraperitoneally. The control (saline/
ethanol 1%) were given orally 1 h before the subplantar injection of the phlogistic agent [23].
Cytokine quantification: Based on a previous test (neutrophil migration assay), the MSE and
the bioactive AF were selected for the quantification of proinflammatory cytokines. The mice
were treated orally with the MSE or the AF (30 mg/kg) 1h before the administration of inflam-
matory stimulation by intraperitoneal (i.p.) injection of carrageenan at 500 μg/mL. After 4 h, the
animals were euthanized and the exudate fluid was collected from peritoneal cavities and
homogenized by using a vortex in a 500 μL of the appropriate buffer containing protease inhibi-
tors (Sigma, St. Louis, MO, USA). TNF-α and IL-1β levels of both experiments were determined
by ELISA using protocols supplied by the manufacturers (Peprotech, Rocky Hill, NJ, USA).
Osteoclastogenic assays. Cell culture: RAW 264.7 cells were purchased from the Rio de
Janeiro cell bank (BCRJ code: 0212; Rio de Janeiro, RJ, Brazil) and cultured in Dulbecco’s Mod-
ified Eagle’s Medium (Life Technologies, Carlsbad, CA, USA). The culture medium contained
phenol red and L-glutamine supplemented with 10% (v/v) of serum fetal bovine (Life Technol-
ogies, Carlsbad, CA, USA), penicillin/streptomycin (100 U/mL, Invitrogen Life Technologies,
CA) and cultured in a T75 flask (Corning Inc., New York, NY, USA). Cells were maintained in
a humidified incubator at 37°C in 5% CO2 and subcultured once a week at a 1: 20 ratio follow-
ing harvesting with a cell scraper and receiving a fresh new medium [9].
Cell viability: A cell-based assay to screen the MSE and fractions (HF, CLF, EAF, AF) to
measure the enzyme activity as a marker of viable cells. RAW 264.7 cells were seeded (~ 1x105
cells/mL) in a 96-well plate and incubated for 24 h at 37°C with 5% CO2. The MSE and frac-
tions were first diluted in ethanol 1% and then (0.1–1000 μg/mL) added to the cell culture seri-
ally and incubated for 24 h. After incubation, the supernatant was discarded and the cells were
washed with PBS. Fresh medium solution without phenol red and with 3-(4,5-dimethylthiazol-
2-yl)-2,5-diphenyltetrazolium (MTT) 0.5 mg/mL was then incubated (10 μL per 100 μL
medium) for an additional 4 h. Afterward, the cell growth medium was replaced by 0.04 N HCl
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in isopropanol and colorimetric measurements were performed with a microplate reader (Asys
HiTech GmbH, Cambridge, United Kingdom) at 570 nm [24].
Analysis of gene expression: Quantitative PCR (qPCR) was performed to evaluate the possi-
ble effects of MSE and fractions on the expression of predominant osteoclast marker genes. In
addition, it was evaluated whether the natural products could control the transcription of the
genes involved in bone metabolism. The genes analyzed were: carbonic anhydrase II (CAII),
cathepsin K (Ctsk), tartrate-resistant acid phosphatase (TRAP) and glycerol 3 phosphate dehy-
drogenase (GAPDH). The primer sequences were: CAII (forward: TGGTTCACTGGAACACCAA,
reverse: CACGCTTCCCCTTTGTTTTA), Ctk (forward: CAGCTTCCCCAAGATGTGAT, reverse:
AGCACCAACGAGAGGAGAAA), TRAP (forward: CCCTCTGCAACTCTGGACTC, reverse:
TAGAGGCGAACAGGAAGGAA), GAPDH (forward: AACTTTGGCATTGTGGAAGG, reverse:
ACACATTGGGGGTAGGAACA). RAW 264.7 cells (~ 1x106 cells/mL) were seeded in 24-well
plates for 24 h and treated with a 10 μg/mL concentration of the MSE and fractions in serum-
free medium for 24 h. The stimulatory response was induced by 1 μg/mL LPS (Escherichia coli,
Sigma Aldrich, St. Louis, Mo). Cultures were washed twice with PBS and RNA was subse-
quently isolated using the RNeasy Mini Kit (Qiagen, Valencia, CA, USA) following the manu-
facturer’s protocols. RNA was treated with the DNase Set (Qiagen, Valencia, CA, USA). The
cDNA was synthesized from total RNA using the SuperScript1 III First-Strand Synthesis Sys-
tem and random primers (Invitrogen, Carlsbad, CA, USA). The relative transcript amounts
were quantified by qPCR with 10 ng of each cDNA and SYBR Green PCRMaster Mix (Applied
Biosystems, Foster City, CA, USA). The reactions were performed in the instrument StepOne-
Plus™ (Applied Biosystems, Foster City, CA, USA). GAPDH was used as an endogenous con-
trol. The relative gene copy number was calculated using the 2ΔΔCT method [25].
TRAP staining: To examine the effect of the MSE and fractions on sRANKL-induced osteo-
clastogenesis in RAW 264.7 macrophage cells, a quantitative measurement was conducted.
Osteoclast formation was measured by the quantification of TRAP+ multinucleated osteoclasts
per well, using light microscopy. RAW 264.7 cells were seeded in 96-well plates (~5x103 cells/
mL), stimulatory response was induced by sRANKL (50 ng/mL) and treated with the MSE and
fractions at 10 μg/mL, and the cell culture medium was α-MEM (Sigma Aldrich, St. Louis, MO,
USA) with 10% fetal bovine serum (Life Technologies, Carlsbad, CA, USA). After 6 days, cells
were fixed with 4% paraformaldehyde, washed with PBS, and stained for TRAP (Sigma
Aldrich, St. Louis, MO, USA). TRAP-positive multinucleated (>3 nuclei) cells were counted as
osteoclast-like cells [9].
Gelatin zymography. RAW 264.7 cells (~ 1x106 cells/mL) were seeded into 24-well plates
for 24 h. Inflammatory response was induced by 1 μg/mL LPS for 48 h (Sigma Aldrich,
St. Louis, Mo). The test concentrations of the MSE and the HF, CLF, EAF and AF were 10 μg/
mL. The supernatant was collected and the amount of total protein was measured using the
Pierce BCA Protein Assay Kit (Thermo Scientific, Rockford, IL, USA). An equal amount of
protein was designed by electrophoresis in Tris-Glycine Gel (Novex1, Life Technologies,
Carlsbad, CA) under non-reducing conditions. The protein separated in the gel was developed
using manufacturer-supplied developing buffer (Novex1, Life Technologies, Carlsbad, CA).
Subsequently, the developed gelatin gel was stained with Coomassie R-250 stain [9].
Antioxidant assays. DPPH: The chemical reactions comprised in 0.5 mL of MSE and frac-
tions, 3.0 mL of absolute ethanol, and 0.3 mL of DPPH radical in a 0.5 mM ethanol solution, at
room temperature incubation for 45 min, and the activity quantified in μmol Trolox/g of sam-
ple dry weight. The calibration curve was generated using a concentration range of the stan-
dard compound Trolox. Several MSE and fraction concentrations were used, and readings
were monitored at 517 nm using a spectrophotometer (Shimadzu, Japan). The antioxidant
activity measured by the DPPH free radical method can be expressed as IC50, i.e., the
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antioxidant concentration required to reduce the initial DPPH radical by 50%. The sample
concentration required the initial DPPH radical by 50% [26].
ABTS•+: The antioxidant activity by the ABTS•+ method (2,20-azinobis-3-ethylbenzothia-
zoline-6-sulfonic acid) was assessed according to the method described by Re et al. (1999) [27]
with modifications. The ABTS radical was formed by the reaction of 7 mM ABTS•+ solution
with 140 mM potassium persulfate solution, incubated at 25°C in the dark for 12–16 h. Once
formed, the radical was diluted with ethanol (analytical grade) to an absorbance of
0.700 ± 0.020 at 734 nm. Three different dilutions of each of the samples were prepared inde-
pendently in triplicate. After that, 30 μL of the MSE and fraction dilution were transferred to
test tubes with 3.0 mL of ABTS radical in the dark. The absorbance was read at 734 nm after 6
min of reaction using ethanol as a blank. Trolox, a synthetic water-soluble antioxidant analog
of vitamin E, was used as the reference at concentrations ranging from 100 to 2000 μM, and
the results were expressed as μMTrolox/g sample.
Chemical analysis
HPLC analysis. A Shimadzu SCL-10Avp system equipped with photodiode array detector
(SPD-M10Avp, Shimadzu Co., Kyoto, Japan), a SIL-10AF auto injector and LC-6AD pumps
were used to perform the high-performance liquid chromatography (HPLC) analysis. For the
analytical test, diluted AF solution at 1.1% in methanol/water (80/20, v/v) was filtered (Milli-
pore– 0.22 μm) and aliquots of 20 μL were injected into an ODS-A column (4.6 mm x 250 mm,
5 μm) maintained at a constant temperature of 28°C. The mobile phase consisted of water/for-
mic acid (99.9/ 0.1, v/v) (solvent A) and acetonitrile/formic acid (99.9/ 0.1) (solvent B) at a con-
stant flow rate of 1.0 mL/min. The gradient started with 5% B and increased to 7% B (7 min),
20% B (50 min), 45% B (70 min), 100% B (85 min), held at 100% B for 10 min, and decreased
to 5% in 100 min. The chromatograms were analyzed using Class-VP1 software; in addition,
authentic standards of phenolic acids (gallic acid, p-coumaric acid, ferulic acid, caffeic acid, syr-
ingic acid, sinapic acid, vanillic acid) and flavonoids (quercetin, rutin, quercetin-3-β-D-gluco-
side, procyanidin B1, procyanidin B2, catechin and epicatechin) (Sigma-Aldrich, St. Louis,
MO, USA) were examined [26].
Mass spectrometric analysis of the bioactive fraction. The tandem mass spectrometry
(MS/MS) system employed to confirm analyte identities was a Quattro LC triple quadrupole
(Micromass, Manchester, UK) fitted with a Z-electrospray (ESI) interface operating in negative
ion mode. The temperatures of source block and desolvation gas were set at 100°C and 450°C,
respectively. Nitrogen was used as both desolvation (nearly 380 L/h) and nebulizer (nearly 38
L/h) gas, while argon was used as the collision gas. The voltages employed in the ESI source
during the analyses were 40 V for the cone, 3 kV for the capillary and 3 V for the extractor. For
rutin identity confirmation, the analyses were carried out in multiple-reaction monitoring
(MRM) mode using collision energies of 15–25 eV. ESI positive and negative modes were
employed. For ESI positive mode, protonated ions [M+H]+ (m/z 611) and sodiated ion [M
+Na]+ (m/z 633) as well as their respective product ions were monitored. For ESI negative
mode, deprotonated ion [M-H]- (m/z 609) and its respective product ions were monitored. For
this analysis, 23.8 mg of the AF were diluted with 1 mL MeOH: 0.1% formic acid (1:1, v/v) and
injected into the LC-MS/MS system under a flow of 20 μL min-1. Table 1 presents the ion tran-
sitions under MRMmode employed to monitor for rutin in the sample.
Statistical analysis
Continuous variables are presented as mean values ± SD. The Shapiro-Wilk test was used for
the assessment of normality. All reported p-values are compared to a significance level of 0.05.
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For multiple group comparisons, the data were subjected to a one-way analysis of variance
(ANOVA). Means and Tukey's significant difference for pair-wise differences in group com-
parisons were used to determine overall difference between the groups. The Bonferroni post-
test indicated a significant difference between the controls. Data were analyzed using STATA™
(version 10.0, Stata Corporation, College Station, TX, USA) and GraphPad (version 5.0,
GraphPad Software Inc., San Diego, CA).
Results
Pharmacological analysis
Neutrophil migration in the peritoneal cavity. The MSE and fractions were primarily
tested for anti-inflammatory effects using a neutrophil migration model as an in vivomodel to
screen for anti-inflammatory compounds. The results showed that the oral administration of
30 mg/kg of the MSE decreased the influx of neutrophils into the peritoneal cavity compared
to the carrageenan group (ρ<0.05). The HF fraction did not present any biological activity in
all doses tested (ρ>0.05). The CLF and AF groups had no statistical differences between the 3,
10 and 30 mg/kg doses. For the EAF group the highest dose of 30 mg/kg was more efficient
than lowest one 3 mg/kg (ρ<0.05).
The fractionation method used for the MSE was effective, showing that the CLF, EAF and
AF concentrated the biological activity and reduced the neutrophil influx in all doses tested.
However, the AF yielded the best results, showing a significant reduction of neutrophil migra-
tion in all doses tested and the lowest percentages of inflammatory cells compared to the other
fractions (Fig 1).
Carrageenan-induced paw edema. The MSE and the bioactive AF were verified for antie-
dematogenic activity. The results for the AF demonstrated a biological activity in the first hour
analyzed. AF was comparable to the positive control indomethacin for the second and third
hours analyzed as shown in (Table 2).
Cytokine assay. The administration of the AF at a dose of 30 mg/kg significantly reduced
the level of cytokine IL-1β (54%) compared to the control group vehicle (p<0.05). Thus, non-
significant differences were found at TNF-α expression levels (Fig 2).
Cell viability assay. The viability test showed a concentration-dependent effect, where the
MSE, HF, and CLF at concentrations higher than 10 μg/mL were toxic for the cells. The AF
and EAF did not affect the cell viability at any of the concentrations tested when compared to
the control group (non-treated) (p>0.05) (Fig 3).
Analysis of gene expression. Gene expression analysis showed that the AF was the only
treatment that had the ability to downregulate all the study genes: CAII, Ctsk and TRAP
(p<0.05) (Figs 4, 5 and 6). The EAF and AF fractions had the ability to suppress the transcrip-
tion of CAII compared to the control group with LPS (p<0.05) (Fig 4).
Table 1. Ion transitions under MRMmode employed to monitor for rutin in the sample.
Compound Ionization mode Molecular ion Fragments/Productions
(m/z)*
Positive 611 [M+H]+ 464, 303, 147, 129
Rutin Positive 633 [M–H]- 486, 331, 324, 133
Negative 609 [M+Na]+ 301, 271, 179, 151
*mass number/charge number
doi:10.1371/journal.pone.0162728.t001
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Fig 1. Inhibitory effect of the MSE, HF, CLF, EAF, AF on neutrophil migration into the peritoneal cavity induced by
carrageenan. Neutrophil migration was determined 4 h after the injection of carrageenan 500 μg/cavity. Mice previously
treated with the vehicle, MSE (ethanol extract ofM. sylvestris), HF (hexane fraction), CLF (chloroform fraction), EAF (ethyl
acetate fraction) and AF (aqueous fraction). The data are expressed as mean ± SD, n = 6. Symbols indicate statistical
difference (p < 0.05, ANOVA, Tukey’s post-test) ** compared to the carrageenan group; * comparison between the
concentrations tested of 3, 10 and 30 mg/kg.
doi:10.1371/journal.pone.0162728.g001
Effects ofMalva sylvestris Extract and Fractions
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Table 2. Effect of MSE and the AF on carrageenan-induced paw edema onmice.
Treatment (mg/kg) Mean edema ΔVmL percent inhibition
1 2 3 4 5
Control 0.08±0.02 0.13±0.02 0.17±0.01 0.12±0.02 0.12±0.02
Indomethacin 10 0.05±0.03 (37.5%) 0.05±0.03* (61.5%) 0.08±0.02* (52.9%) 0.08±0.02* (33.3%) 0.08±0.02* (33.3%)
MSE 30** 0.06±0.02 (25%) 0.08±0.02* (38.4%) 0.07±0.01* (58.8%) 0.11±0.03 (8.3%) 0.11±0.03 (8.3%)
AF 30*** 0.04±0.01* (50%) 0.06±0.02* (53.8%) 0.07±0.02* (58.8%) 0.10±0.02 (16.6%) 0.09±0.02 (25%)
All the data are expressed as mean ± SD, n = 6.
*Symbol indicate statistical difference (p < 0.05, ANOVA, Bonferroni post-test) and compared to the control) group.
**MSE:M. sylvestris extract,
***AF: aqueous fraction.
doi:10.1371/journal.pone.0162728.t002
Fig 2. Quantification of TNF-α and IL-1β in the peritoneal cavity.Mice were previously treated with the
vehicle, the MSE and the AF at a dose of 30 mg/kg 1h before the carrageenan injection. Data are expressed as
mean±SD, n = 6. Symbols indicate statistical difference (p<0.05, Dunnett’s test); *p<0.05 compared to the
carrageenan group.
doi:10.1371/journal.pone.0162728.g002
Fig 3. Effect of MSE and fractions on cell viability. Log dose response of MSE, HF, EAF, and AF on RAW
264.7 cells. Significant difference between fractions at the indicated dose (p<0.05). **Significant difference
between IC50 values (p < 0.05). Data were expressed as mean±SD, n = 9.
doi:10.1371/journal.pone.0162728.g003
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Fig 4. Effect of MSE and fractions onCAII (carbonic anhydrase II) expression levels.Quantification of
the relative transcript amounts performed by qpcR with 10 ng of each cDNA. Data quantification was
performed using 2(-DeltaDeltaC(T)). Statistical analyses were performed by one-way ANOVA followed by
Dunnett’s post-hoc tests. *p<0.05 significantly different from LPS-stimulated cells.
doi:10.1371/journal.pone.0162728.g004
Fig 5. Effect of MSE and fractions onCtsk (cathepsin K) expression levels.Quantification of the relative
transcript amounts performed by qpcR with 10 ng of each cDNA. Data quantification was performed using 2
(-DeltaDeltaC(T)). Statistical analyses were performed by one-way ANOVA followed by Dunnett’s post-hoc
tests. *p<0.05 significantly different from LPS-stimulated cells.
doi:10.1371/journal.pone.0162728.g005
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The gene transcription of Ctsk was controlled by the treatments with the AF and EAF
(p>0.05) (Fig 5).
The MSE, CLF, EAF and AF downregulated the gene expression of TRAP (p>0.05) (Fig 6).
Tartare-resistant acid phosphatase activity assay. The number of TRAP-positive cells
showed high expression levels in the stimulated control group (p<0.05). The CLF and AF treat-
ments had the ability to reduce the osteoclastogenesis in RAW 264.7 cell lines (p<0.05) (Fig 7).
Gelatin zymography. The results showed that two different fractions caused the reduction
of gelatinolytic activity: the AF and EAF at the 10 μg/mL concentration. The non-treated group
and the AF, EAF were not significantly different (p>0.05). In this study, MMP-9 activity
decreased 69% and 75% (AF and EAF, respectively). In contrast, HF and CLF increased the
enzyme activity (Fig 8).
DDPH and ABTS•+ assay. The results are presented in Table 3 and show that when the
ABTS•+ method was used, the AF and EAF had the highest antioxidant activity (1.3 μmol Tro-
lox/g and 1.1 μmol Trolox/g, respectively).
Based on the DPPH method results, the samples where the concentration reduced the initial
amount of DPPH radical by 50% were the EAF (0.94 g/L), followed by the AF (1.01 g/L), and
the CLF (1.78 g/L). The lowest IC50 values can be considered good results in terms of antioxi-
dant activity, given that a low concentration is required to reduce the DPPH free radical by
50%.
Chemical analysis
HPLC analysis. The HPLC analysis was used for the bioassay-guided fractionation and
the major compound of the AF was identified and represented (Fig 9). The peak corresponding
to rutin was identified at retention time 47.58 min and UV absorbance at 350 nm.
Fig 6. MSE and fractions effect on TRAP (tartrate-resistant acid phosphatase) expression levels.
Quantification of the relative transcript amounts performed by qpcR with 10 ng of each cDNA. Data
quantification was performed using 2(-DeltaDeltaC(T)). Statistical analyses were performed by one-way
ANOVA followed by Dunnett’s post-hoc tests. *p < 0.05 significantly different from LPS-stimulated cells.
doi:10.1371/journal.pone.0162728.g006
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Fig 7. Activity ofM. sylvestris and fractions in RANKL-mediated osteoclast differentiation. RAW 264.7
cells were stimulated with sRANKL (50 ng/ml) for 6 days. Cells were fixed and stained for TRAP. TRAP
+ multinuclear cells were counted. Data represent mean ± SD of three cultures. * p<0.05; significantly lower
than sRANKL-stimulated group.
doi:10.1371/journal.pone.0162728.g007
Fig 8. Effect of MSE and fractions on MMP-9 expression levels. Proteolysis activity was stimulated by
LPS (E. coli) 1 μg/mL. Supernatant was mixed 1:1 with sample buffer and then applied to the gels.
Quantification was performed by peak area and normalized by the protein ladder band. Data quantification
was performed using ImageJ software. Statistical analyses were performed by one-way ANOVA followed by
Dunnett’s post-hoc test. *p<0.05 significantly different from LPS-stimulated cells.
doi:10.1371/journal.pone.0162728.g008
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Mass Spectrometric Analysis of Bioactive Fraction (Aqueous Fraction). For identity
confirmation of rutin, ESI positive and negative modes were employed. For ESI positive mode,
protonated ion [M+H]+ (m/z 611, Fig 10) and sodiated ion [M+Na]+ (m/z 633, Fig 11) as well
Table 3. Antioxidant activity of MSE and fractions using ABTS•+ and DPPHmethod.
Antioxidant activity
Groups IC50 DPPH (mg/mL) ABTS
•+ (μmol Trolox/g)
MSE 2.62±0.08a 0.34±0.03a
HF 6.01±1.78b 0.25±0.02a
CLF 1.78±0.20c 0.64±0.10a
EAF 0.94±0.04d 1.10±0.20b
AF 1.01±0.06d 1.30±0.20b
Reference values: BHT (0.1 mg/mL)__ 1268± 15 μmol Trolox/g (ABTS•+), (184 ± 2.6 μmol Trolox/g (DPPH).
Averages of triplicates ± SD/means followed by letters showing the columns that differ statistically (p<0.05).
Tukey's multiple comparison test. DPPH: 2,2-diphenyl-1-picryl-hydrazine; ABTS: 2,20-azino-bis-
3-ethylbenzothiazoline-6-sulfonic acid, BHT (butilhidroxitolueno).
doi:10.1371/journal.pone.0162728.t003
Fig 9. Analytical HPLC-PAD chromatogram of the AF of the ethanol extract ofM. sylvestris recorded at UV 350 nm.
doi:10.1371/journal.pone.0162728.g009
Fig 10. Mass spectrum on ESI positive mode under MRMmonitoring for molecular ion m/z 611.
doi:10.1371/journal.pone.0162728.g010
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as their respective product ions were monitored. For ESI negative mode, the deprotonated ion
[M-H]- (m/z 609, Fig 12) and its respective product ions were monitored.
Discussion
The complexity of non-resolving inflammation and the lack of understanding it render phar-
macological therapy difficult [1]. Multipronged therapeutic approaches are needed to treat
chronic inflammatory diseases, and the most potent drug interventions may increase the risk
of adverse effects [28]. Glucocorticoids are commonly used as a reference drug when treating
chronic inflammation, and their major adverse effect is additional bone loss [29].
Many epidemiological and experimental studies suggest that natural products may have the
ability to decrease oxidative and inflammatory processes, and that their use as dietary products
can help prevent chronic diseases [30]. The MSE and fractions were primarily tested for anti-
inflammatory effects using the neutrophil migration model as an in vivo activity screening
model. These findings showed that the extract and all the fractions, except the HF, were to
reduce the number of neutrophils migrating into the carrageenan-induced peritonitis. How-
ever, with the bioguided method of fractionation, we were able to establish that the AF concen-
trated the active compound and presented the most significant anti-inflammatory reduction.
The mechanisms involved in the inhibition of neutrophil migration to the damage site are
accompanied by the reduction in inflammatory markers and oxidative stress [31]. The AF pro-
moted the significant reduction of cytokine IL-1β, which is involved in the release of
Fig 11. Mass spectrum on ESI positive mode under MRMmonitoring for molecular ion m/z 633.
doi:10.1371/journal.pone.0162728.g011
Fig 12. Mass spectrum on ESI negative mode under MRMmonitoring for molecular ion m/z 609.
doi:10.1371/journal.pone.0162728.g012
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prostanoids [32]. The release of pro-inflammatory cytokines is related to the migration process,
and induces the rolling and adhesion of neutrophils in the vascular endothelium and transmi-
gration to the inflammatory site [1]. The results revealed that IL-1-1β, but not TNF-α, was sup-
pressed, and they have different functions even when they present many proinflammatory-
shared activities [33]. Using a chronic inflammatory in vivomodel, authors support the main
role of TNF-α being linked to mediating inflammation and IL-1β controlling bone metabolism,
its destruction and inflammation properties [33,34]. In this way, the putative mechanism asso-
ciated with this activity may be due to the inhibition of the synthesis of cytokines such as IL-1β,
which are involved in tissue degradation, as well as to inflammatory process interfering with
cell migration [35].
The carrageenan paw edema was accessed to verify the potency of the AF in the inflamma-
tion process [36]. The biphasic nature of edema is key in the role of the inflammatory response
[37]. In the first phase (0-3h) there is an increase in histamine, serotonin and chemical media-
tors, and these are related to the greater vascular permeability and production of cytokines
such as IL-1β and TNF-α [23]. The second phase of the edema is characterized by the recruit-
ment of prostaglandins, proteases, mediators and most of the available anti-inflammatory
drugs are useful to suppress it [38]. The results of the AF treated orally (30 mg/kg) showed an
anti-inflammatory activity equal to the positive control indomethacin given intraperitoneally
(10 mg/kg). In this way, the anti-inflammatory effect of the fraction may be due to the suppres-
sion of the cyclooxygenases involved in the formation of prostaglandins.
This study demonstrated that the AF and EAF had a significant inhibitory effect on MMP-9
accessed by zymography. MMP-9 (gelatinase B, 92 KDa Type IV) is produced in the cell envi-
ronment and activated after release into the extracellular space [9]. This protein is involved in
the breakdown of the extracellular process of bone development and may be found in many
pathological conditions, such as arthritis and tumor metastasis [39]. The use of natural prod-
ucts to inhibit MMPs may contribute to attenuating the proteolysis of the extracellular matrix
and the role in bone osteoclast resorption [40].
Osteoclasts are formed by the fusion of hematopoietic cells of monocyte-macrophage line-
age during the differentiation process [41]. RAW 264.7 cells are precursors and can express
phenotype marker genes such as TRAP and Ctsk, which represent the expression of mature
osteoclasts [42]. The AF was able to reduce the expression of both genes and the enzyme CAII,
which is overexpressed during the bone resorption process. Despite the lack of scientific infor-
mation about natural products and bone-protective effects, it is known that flavonoids, a com-
mon class of natural products, have shown promise in the area of health promotion related to
dietary components like calcium and vitamin D [43]. Flavonoids have been related to the activ-
ity of the signaling pathways that influence the osteoblast in an osteoclast difference. Consistent
with this study, authors have tested an osteoclast differential in vitromodel on RAW 264.7
cells and reported a therapeutic potential in a traditional Chinese herb for reducing the TRAP,
MMP-9, Ctsk genes in this way, showing an ability to interact directly with the bone cells (oste-
oblasts, osteoclasts, osteocytes) [44].
Some tests that evaluate radical scavenging capacity may contribute to the etiology of vari-
ous degenerative diseases, particularly those related to the chronic inflammation process [28].
When sequestering, radical antioxidants can regulate the oxidation pathway [45]. The ABTS
and DPPH assays conducted onM. sylvestris and fractions screened the biologically antioxi-
dant activity and related it to the bone remodeling effect. In a previous report, it was indicated
that sameM. sylvestris extract and fractions contained several classes of phenolic compounds
that may be responsible to antioxidant effects [21]. Thus, authors demonstrated a linear corre-
lation between the phenolic content and antioxidant effects [46]. In agreement with this study,
other investigations have reported the highest antioxidant activity for the AF using the β-
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carotene-linoleic acid method [16]. In particular, the literature shows that extracts obtained
from leaves, as MSE were, have a very strong antioxidant property and the activity is tied to the
region where the plant was collected, with the strongest obtained fromM. sylvestris extracts
found in northeastern Portugal [18].
The chemical analysis of the AF identified the bioactive compound rutin. This compound is
a common flavonoid used in plant-derived beverages, food and folk medicine. Studies have
reported diverse pharmacological activities of rutin, including promoting health and reducing
risk of chronic diseases. In particular and consistent with this study, research has found rutin
to be an anti-inflammatory drug candidate with a unique mechanism for selective COX-2 [47].
Authors have also reported that rutin could inhibit more than 20 genes coding for critical pro-
inflammatory factors including TNF-α, IL-1β, IL-1 and IL-8, and migration inhibitory factor
[48]. Rutin appears to be a potential phytochemical ingredient for chronic inflammatory treat-
ment or even a promising functional food for the market.
Conclusion
The AF ofM. sylvestris presented the capacity for anti-inflammatory, anti- oesteoclasteogenic
and antioxidant activities. In addition, we suggest that the bioactive fraction and its major com-
pound rutin may be a good candidate for drug discovery in the therapy of chronic inflamma-
tory diseases.
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